Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 53 | 49 | −4 |
| Shares | 9.94M | 9.17M | −767.9K (−7.7%) |
| Value | $112.3M | $114.6M | +$2.31M (+2.1%) |
New holders (5)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parametric Portfolio Associates LLC | 12,465 | $156.0K | 0.00% |
| HighVista Strategies LLC | 10,944 | $137.0K | 0.09% |
| Benjamin F. Edwards & Company, Inc. | 500 | $6.00K | 0.00% |
| Group One Trading, L.P. | 400 | $5.00K | 0.00% |
| Cutler Group LP | 300 | $3.00K | 0.00% |
Sold out (9)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 93,259 | $1.05M |
| Marshall Wace, LLP | 31,425 | $355.0K |
| Jump Financial, LLC | 16,474 | $186.0K |
| Two Sigma Investments, LP | 16,316 | $184.0K |
| PDT Partners, LLC | 16,200 | $183.0K |
| Meeder Asset Management Inc | 4,150 | $47.0K |
| Knott David M | 1,375 | $16.0K |
| Signaturefd, LLC | 65 | $1.00K |
| Parallel Advisors, LLC | 87 | $1.00K |